TrialDiabetologia2019

The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.

Shiu Lun Au Yeung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.